Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,744 GBX | +0.22% | -2.54% | +20.19% |
May. 28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.19% | 90.67B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.28% | 238B | |
+7.16% | 204B | |
-6.22% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK, Hansoh Pharma Enter Exclusive License Deal for HS-20089